Search
Powered By HealthLine
Health Tools
 Children's Allergies Q&A
 Childhood Asthma Guide
 Childhood Asthma Prognosis
 Identifying Depression in Children
 Treating Childhood Depression
Featured Conditions
 Cold & Flu
 Allergy
 Asthma
 Depression
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Medical Studies Involving Kids May Be Prone to Bias

Industry-funded trials at greater risk of distortion than nonprofit or government-sponsored: review


Related Encyclopedia
 border=
Acne
Alagille Syndrome
Appendicitis
Asthma in Children
More...

Related Animations
 border=
Dental Cavities
More...

Related Healthscout Videos
 border=
Gene Screen for Cancer Triggers
Blood Lies
Signing Babies, Smarter Babies?
Concussions and Kids: Double Impact
More...

Related Drug Information
 border=
Adderal XR
Concerta
Strattera
More...

Related News Articles
 border=
Health Tip: Create an Asthma Action Plan for School
Adults Reminded to Keep Kids Away From Lawn Mowers
Health Tip: Make Sure Your Child's Shoes Fit
Energy Drink-Vodka Combo Nearly Kills Teen
More...

WEDNESDAY, July 14 (HealthDay News) -- A review of nearly 150 recently published studies on children's health found that approximately half were at serious risk for bias and distorted results, researchers say.

The Johns Hopkins review of pediatric clinical trials found that 40 to 60 percent either had design flaws that could result in bias or that the researchers did not properly describe steps they had taken to minimize that risk.

Text Continues Below



The finding, reported in the August issue of Pediatrics, stems from a review of 146 randomized controlled trials on children that appeared in one of eight prominent medical journals between 2007 and 2008, including Pediatrics, Pediatric Infectious Diseases, Journal of Pediatrics, Archives of Pediatrics and Adolescent Medicine, Journal of the American Academy of Child and Adolescent Psychiatry, the Journal of the American Medical Association, the New England Journal of Medicine and The Lancet.

Led by pediatrician Dr. Michael Crocetti of the Johns Hopkins Children's Center in Baltimore, the review authors noted that all the journals are well-regarded and that the latter three are the highest ranking general interest medical journals in the world.

"There are thousands of pediatric trials going on in the world right now, and given the risk that comes from distorted findings, we must ensure vigilance in how these studies are designed, conducted and judged," Crocetti said in a news release from the journal's publisher. "Our review is intended as a step in that direction."

To get a handle on potential bias problems in trials involving children, Crocetti and his colleagues looked at how well the studies handled the random assigning of patients to varying treatment options -- a key hallmark of "gold-standard" research.

In addition, they examined to what degree patients and doctors were unaware of whether or not any particular patient was receiving a trial medication or a sugar-pill substitute (called a placebo).

Page:  1 | 2 | Next >>

-- Alan Mozes

Copyright © 2010 HealthDay. All rights reserved.
Last updated 7/14/2010

Related Links
 border=
From Healthscout's partner site on adhd, ADHDCentral.com
Find tips for parenting children with ADHD
Learn how to cope with Adult ADHD
What treatment options are available for ADHD?




SOURCE: Pediatrics, news release, July 12, 2010


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2011. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire